LobbyingBreak Through Cancer lobbying by quarter
Break Through Cancer's latest lobbying report covers Q2 2024, at under $5,000. Its first report covers Q3 2023; the issues it reports most are Health Issues and Medicare/Medicaid.
Break Through Cancer
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $20K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $20K | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$30K · 3 reports
- Medicare and Medicaid$30K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)3 reports
- HOUSE OF REPRESENTATIVES3 reports
- SENATE3 reports
Firms it paid
| Firm | ||
|---|---|---|
| The Federal Group | $60K | 4 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/08/08for Q2 2024 | The Federal Group | Under $5,000 |
| 24/05/28for Q1 2024 | The Federal Group | $20K |
| 24/01/08for Q4 2023 | The Federal Group | $20K |
| 24/01/08for Q3 2023 | The Federal Group | $20K |
| 23/07/31for Q3 2023 | The Federal Group | Under $5,000 |